AN
50
-2
NOC
41
-2
GE
62
-2
ABBV
48
-2
TMO
54
-2
HBI
53
-5
JNPR
60
-2
IBM
53
-2
VFC
54
-4
LNC
29
-3
EXR
30
-3
PM
47
-3
IPG
39
-4
GM
61
-2
IP
50
-6
LB
37
2
MTCH
55
-2
CMCSA
50
-3
EQR
36
-3
M
50
-5
AN
50
-2
NOC
41
-2
GE
62
-2
ABBV
48
-2
TMO
54
-2
HBI
53
-5
JNPR
60
-2
IBM
53
-2
VFC
54
-4
LNC
29
-3
EXR
30
-3
PM
47
-3
IPG
39
-4
GM
61
-2
IP
50
-6
LB
37
2
MTCH
55
-2
CMCSA
50
-3
EQR
36
-3
M
50
-5
Financhill
Back

Edwards Lifesciences 10K Form

Buy
55

EW
Edwards Lifesciences

Last Price:
$74.28
Seasonality Move:
5.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-29 10Q EW/Edwards Lifesciences Quarterly
2024-02-12 10K EW/Edwards Lifesciences Annual
2023-10-27 10Q EW/Edwards Lifesciences Quarterly
2023-07-28 10Q EW/Edwards Lifesciences Quarterly
2023-04-28 10Q EW/Edwards Lifesciences Quarterly
2023-02-13 10K EW/Edwards Lifesciences Annual

Receive EW News And Ratings

See the #1 stock for the next 7 days that we like better than EW

EW Financial Statistics

Sales & Book Value

Annual Sales: $6B
Cash Flow: $294.5M
Price / Cash Flow: 93.13
Annual Sales: $16.18
Price / Book: 4.67

Profitability

EPS (TTM): 6.93000
Net Income (TTM): $4.2B
Gross Margin: $4.6B
Return on Equity: 55.09%
Return on Assets: 40.35%

Edwards Lifesciences Earnings Forecast

Key Edwards Lifesciences Financial Ratios

  • The Gross Profit Margin over the past 25 years for EW is 77.02%.
  • The Selling, General & Administrative Expenses for EW have been equal to 30.39% of Gross Profit Margin.
  • The Research & Development expenses have been 17.85% of Revenue.
  • The Interest Expense is 1.25% of Operating Income.
  • The Net Earning history of EW is 23.35% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 17 years.

Edwards Lifesciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: EW
CUSIP: 28176E
Website: edwards.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 3.46
Quick Ratio: 2.7

Price-to-Earnings

Trailing P/E Ratio: 32.89
Forward P/E Ratio: 30.69

EW Technical Analysis vs Fundamental Analysis

Buy
55
Edwards Lifesciences (EW) is a Buy

Is Edwards Lifesciences a Buy or a Sell?